13223
clinical study

Engineering Structural Workflow Efficiencies in the Outpatient Imaging Center: The Synthesis of Human Intervention (HI) and Artificial Intelligence (AI) for Actionable Incidental Findings

Materials & Methods

After IRB approval, AI software was implemented at outpatient imaging centers to flag incidental pulmonary emboli (iPE) and intracranial hemorrhages (ICH). When a case is flagged, a radiology technician notifies the ARNP, who coordinates with the clinical team for confirmation. If validated, the patient is transferred to the emergency department for further care.

Results

Effective training of ARNPs, radiology technicians and coordinators is crucial for optimizing AI-flagged incidental suspected findings. From July 2023 to Feb. 2024, AI significantly reduced turnaround times (TATs) for positive cases: 71.3 minutes for iPEs (vs. 267.6 minutes for negatives, P<0.05) and 69.15 minutes for ICHs (vs. 176.9 minutes for negatives, P<0.05). AI flagged 51 iPEs and 150 ICHs.

Conclusions

This study highlights the potential of point-of-care AI deployment (POC-AID) to enhance incidental suspected finding management in outpatient imaging centers by enabling rapid detection and timely clinical intervention. By integrating AI with human oversight, radiologists can prioritize critical cases, collaborate with healthcare teams and expedite patient referrals, ultimately improving outcomes and healthcare efficiency.

Disclaimer: This links to a third-party website, which may require credentials to review. 

Explore the Latest AI Insights, Trends and Research

Daniel Spector

<p>Daniel Spector is an AI Transformation Consultant at Aidoc. His focus is enabling clinicians and hospital administrators to provide better, more efficient care through the power of AI augmentation for enterprise imaging.</p>

Amalia Schreier

<p>Amalia Schreier serves as the Senior Vice President of Regulatory Affairs and Legal at Aidoc, guiding our company and product’s regulatory strategies and ensuring alignment with AI-focused medical device compliance requirements. Since her tenure began, she has streamlined our FDA clearance processes, emphasizing a meticulous approach that underscores our commitment to product and clinical quality.</p> <p>With a solid foundation from her legal background and leadership role in AI startup regulatory departments, Schreier brings invaluable insights and expertise to our regulatory framework. Prior to her tech world experience, she worked as a human-rights lawyer and legal policy scholar, with a BA and LLM in law from the Hebrew University of Jerusalem.</p>

Deepak Srikant

<p>Deepak Srikant is a global marketing executive with over 20 years of experience, specializing in the commercialization of medical devices and digital health solutions. He has a proven track record in driving growth, having led successful go-to-market strategies, product launches and market expansions across the U.S. and EMEA.</p> <p>Srikant’s expertise extends to upstream and downstream marketing, professional education and sales enablement. His leadership at companies such as Silk Road Medical (acquired by Boston Scientific) and Aptus Endosystems (acquired by Medtronic) has consistently resulted in revenue growth, enhanced customer retention and successful product adoption.</p> <p>Srikant holds an MBA from the Yale School of Management and a bachelor’s degree in mechanical engineering from Rensselaer Polytechnic Institute. Currently, he leads product marketing for Aidoc’s cardiovascular service line.</p>